The Pennant Group (NASDAQ:PNTG – Get Rating) was downgraded by investment analysts at Stephens from an “overweight” rating to an “equal weight” rating in a research note issued on Tuesday, The Fly reports.
Several other equities analysts also recently commented on the company. Stifel Nicolaus downgraded The Pennant Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $32.00 to $18.00 in a research report on Tuesday, March 1st. Royal Bank of Canada cut their price objective on The Pennant Group from $37.00 to $26.00 and set an “outperform” rating on the stock in a research report on Thursday, March 10th. Finally, Truist Financial upped their price objective on The Pennant Group from $17.00 to $20.00 in a research report on Thursday, April 7th.
NASDAQ PNTG opened at $15.46 on Tuesday. The company has a market cap of $441.07 million, a P/E ratio of 193.25 and a beta of 2.40. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.19 and a current ratio of 1.19. The business’s 50 day moving average price is $16.94 and its 200-day moving average price is $17.48. The Pennant Group has a fifty-two week low of $11.38 and a fifty-two week high of $44.23.
The Pennant Group (NASDAQ:PNTG – Get Rating) last released its earnings results on Monday, May 9th. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.02. The firm had revenue of $113.91 million for the quarter, compared to the consensus estimate of $109.40 million. The Pennant Group had a return on equity of 6.03% and a net margin of 0.62%. During the same quarter in the previous year, the company posted $0.11 EPS. As a group, equities analysts predict that The Pennant Group will post 0.4 EPS for the current year.
In related news, Director Christopher R. Christensen acquired 2,668 shares of the firm’s stock in a transaction that occurred on Monday, April 18th. The stock was purchased at an average cost of $16.50 per share, for a total transaction of $44,022.00. Following the purchase, the director now directly owns 581,133 shares of the company’s stock, valued at approximately $9,588,694.50. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Christopher R. Christensen acquired 21,603 shares of the firm’s stock in a transaction that occurred on Wednesday, April 13th. The shares were bought at an average price of $16.50 per share, with a total value of $356,449.50. Following the completion of the purchase, the director now directly owns 572,736 shares in the company, valued at $9,450,144. The disclosure for this purchase can be found here. 10.30% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently modified their holdings of PNTG. Bank of America Corp DE raised its stake in The Pennant Group by 15.2% in the first quarter. Bank of America Corp DE now owns 102,428 shares of the company’s stock valued at $1,909,000 after buying an additional 13,517 shares during the last quarter. Rice Hall James & Associates LLC purchased a new stake in The Pennant Group in the first quarter valued at about $1,972,000. Keeley Teton Advisors LLC raised its stake in The Pennant Group by 49.4% in the first quarter. Keeley Teton Advisors LLC now owns 49,284 shares of the company’s stock valued at $918,000 after buying an additional 16,304 shares during the last quarter. Jane Street Group LLC purchased a new stake in The Pennant Group in the first quarter valued at about $277,000. Finally, Penn Capital Management Company LLC raised its stake in The Pennant Group by 29.1% in the first quarter. Penn Capital Management Company LLC now owns 65,355 shares of the company’s stock valued at $982,000 after buying an additional 14,728 shares during the last quarter. Hedge funds and other institutional investors own 88.84% of the company’s stock.
The Pennant Group Company Profile (Get Rating)
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Read More
Receive News & Ratings for The Pennant Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for The Pennant Group and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
